Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Conditions: Breast Atypical Hyperplasia; Breast Carcinoma; Breast Ductal Carcinoma In Situ; Breast Lobular Carcinoma In Situ Interventions: Procedure: Biospecimen Collection; Procedure: Mammography; Drug: Omega-3-Acid Ethyl Esters; Other: Questionnaire Administration; Procedure: Random Periareolar Fine-Needle Aspiration; Drug: Tamoxifen Sponsors: National Cancer Institute (NCI) Not yet recruiting

https://clinicaltrials.gov/study/NCT06195306

Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials